XBRA
COM:XBRANE
Xbrane Biopharma
- Stock
Last Close
0.20
21/11 16:29
Market Cap
339.03M
Beta: -
Volume Today
8.50M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 80.46K - | 1.33M 1,551.69% | 2.78M 109.27% | 4.29M 54.44% | 2.76M 35.68% | 25.13M - | 78.56M 212.61% | |||||
average payables | 164.69K - | 2.44M 1,380.46% | 3.56M 46.14% | 6.45M 81.09% | 20.72M 221.19% | 26.00M 25.47% | 25.32M 2.62% | 35.47M 40.08% | 32.34M 8.81% | 27.14M 16.11% | ||
average receivables | 2.29M - | 2.29M 0% | 4.04M 76.04% | 9.28M 129.96% | 5.24M 43.49% | 40.83M - | ||||||
book value per share | 3.69 - | 2.68 27.53% | 20.19 654.37% | 22.56 11.73% | 15.45 31.54% | 12.67 17.95% | 16.47 29.96% | 14.23 13.62% | 18.30 28.62% | 16.62 9.19% | 0.68 95.93% | |
capex per share | -0.08 - | -0.49 512.28% | -2.54 421.62% | -0.58 76.99% | -0.24 58.31% | -0.11 56.49% | -0.21 100.65% | -3.28 1,440.44% | -2.35 28.28% | -0.07 97.18% | ||
capex to depreciation | -3.43 - | -0.80 76.78% | -1.42 77.97% | -0.37 - | -0.16 56.17% | -0.59 262.36% | -5.95 913.59% | -0.50 - | ||||
capex to operating cash flow | 0.07 - | 0.09 31.90% | 0.31 231.27% | 0.09 70.37% | -0.03 137.67% | 0.01 123.35% | 0.02 102.41% | 0.35 2,078.23% | 0.31 11.97% | 0.04 86.70% | ||
capex to revenue | -0.99 - | -2.64 167.85% | -4.85 83.55% | -0.16 96.68% | -0.01 91.22% | -1.98 13,883.65% | -0.57 71.43% | -6.71 1,086.70% | -1.04 84.44% | -0.07 93.27% | ||
cash per share | 3.77 - | 2.64 30.14% | 1.14 56.66% | 6.59 476.84% | 1.38 79.05% | 15.41 1,015.58% | 14.67 4.75% | 13.42 8.52% | 12.51 6.79% | 7.59 39.36% | 0.26 96.60% | |
days of inventory on hand | 228.88 - | 137.65 39.86% | 70.68 48.65% | 126.78 79.38% | 191.81 - | |||||||
days payables outstanding | 6.77K - | 130.30 98.08% | 243.06 86.54% | 709.21 191.78% | 421.46 40.57% | 55.60 - | ||||||
days sales outstanding | 3.86K - | 141.83 - | 33.89 76.10% | 52.31 - | ||||||||
debt to assets | 0.05 - | 0.04 32.73% | 0.01 72.21% | 0.20 1,849.63% | 0.03 85.84% | 0.01 51.52% | 0.06 377.60% | 0.06 14.14% | 0.29 421.87% | |||
debt to equity | 0.09 - | 0.04 53.30% | 0.01 68.31% | 0.60 4,628.71% | 0.05 91.45% | 0.02 52.55% | 0.10 323.18% | 0.09 12.49% | 1.10 1,124.80% | |||
dividend yield | ||||||||||||
earnings yield | -0.03 - | -0.03 22.06% | -0.15 360.53% | -0.18 21.87% | -0.12 33.39% | -0.05 61.99% | -0.43 837.12% | -0.17 61.30% | -0.08 53.85% | -0.08 6.20% | -0.15 86.86% | |
enterprise value | 70.30M - | 72.97M 3.81% | 80.55M 10.38% | 155.54M 93.09% | 363.25M 133.54% | 235.52M 35.16% | 232.43M 1.31% | 1.12B 380.99% | 2.22B 98.73% | 1.94B 12.52% | 2.70B 38.83% | |
enterprise value over ebitda | -33.36 - | -29.65 11.12% | -10.97 62.99% | -6.34 42.25% | -8.11 27.93% | -38.18 370.99% | -1.48 96.13% | -5.11 245.91% | -13.26 159.32% | -11.71 11.65% | -9.75 16.74% | |
ev to operating cash flow | -31.99 - | -27.35 14.51% | -6.50 76.22% | -3.95 39.34% | -9.86 149.87% | 5.04 151.15% | -1.56 131.02% | -4.69 199.78% | -10.12 115.74% | -10.02 0.93% | -6.63 33.80% | |
ev to sales | 370.92 - | 384.83 3.75% | 185.83 51.71% | 62.46 66.39% | 17.49 72.00% | 2.09 88.08% | 387.39 18,479.05% | 163.91 57.69% | 192.65 17.53% | 33.73 82.49% | 11.30 66.49% | |
free cash flow per share | -0.93 - | -1.21 29.95% | -5.75 373.91% | -10.83 88.31% | -7.02 35.16% | 6.88 197.99% | -13.38 294.47% | -13.37 0.07% | -12.59 5.89% | -9.94 21.07% | -1.67 83.17% | |
free cash flow yield | -0.03 - | -0.04 29.95% | -0.17 373.91% | -0.28 65.06% | -0.11 61.50% | 0.16 244.81% | -0.39 345.91% | -0.18 53.78% | -0.12 32.83% | -0.12 0.76% | -0.17 38.19% | |
graham net net | 3.56 - | 2.47 30.59% | -9.19 472.00% | 4.58 149.84% | -1.23 126.96% | -8.88 619.33% | 0.86 109.64% | 2.05 139.15% | 1.63 20.31% | -1.82 211.47% | -1.33 26.67% | |
graham number | 8.63 - | 8.11 5.95% | 47.83 489.41% | 59.61 24.63% | 52.24 12.37% | 24.00 54.06% | 74.47 210.35% | 63.31 14.99% | 57.74 8.80% | 50.18 13.08% | 4.83 90.37% | |
income quality | 1.04 - | 1.04 0.59% | 1.07 3.45% | 1.19 10.67% | 0.82 30.90% | -3.56 534.28% | 0.89 125.13% | 1.05 17.86% | 1.17 10.53% | 1.12 3.58% | 1.26 12.35% | |
intangibles to total assets | 0 - | 0 | 0.77 Infinity% | 0.49 36.78% | 0.57 18.11% | 0.26 54.78% | 0.19 25.16% | 0.13 30.55% | 0.07 46.49% | 0.15 104.72% | 0 100% | |
interest coverage | -1.65K - | -39.23 97.62% | -162.41 313.97% | -346.65 113.44% | -6.54 98.11% | -112.99 1,627.20% | -292.76 159.11% | -68.44 76.62% | -64.35 5.97% | -2.27K 3,421.17% | ||
interest debt per share | 0.00 - | 1.85 279,443.94% | 0.94 49.03% | 0.22 76.91% | 7.85 3,500.79% | 0.97 87.60% | 0.39 60.15% | 1.99 413.76% | 1.60 19.93% | 0.75 53.25% | ||
inventory turnover | 1.59 - | 2.65 66.28% | 5.16 94.76% | 2.88 44.25% | 1.90 - | |||||||
invested capital | 0.09 - | 0.04 53.30% | 0.01 68.31% | 0.60 4,628.71% | 0.05 91.45% | 0.02 52.55% | 0.10 323.18% | 0.09 12.49% | 1.10 1,124.80% | |||
market cap | 79.18M - | 79.18M 0% | 79.18M 0% | 182.59M 130.62% | 370.03M 102.66% | 286.77M 22.50% | 387.19M 35.02% | 1.35B 249.92% | 2.47B 82.49% | 2.10B 15.10% | 2.53B 20.62% | |
net current asset value | 8.69M - | 6.17M 29.05% | -20.39M 430.69% | 32.72M 260.47% | 5.54M 83.05% | -8.16M 247.09% | 93.32M 1,244.19% | 168.43M 80.48% | 304.32M 80.68% | 247.90M 18.54% | -20.48M 108.26% | |
net debt to ebitda | 4.21 - | 2.52 40.19% | -0.19 107.44% | 1.10 687.96% | 0.15 86.26% | 8.31 5,387.93% | 0.98 88.16% | 1.08 10.07% | 1.50 38.16% | 0.94 37.27% | -0.60 163.94% | |
net income per share | -0.90 - | -1.09 22.06% | -5.03 360.53% | -7.00 39.03% | -7.85 12.17% | -2.02 74.28% | -14.97 641.09% | -12.52 16.34% | -8.10 35.34% | -6.74 16.81% | -1.53 77.24% | |
operating cash flow per share | -0.93 - | -1.13 21.43% | -5.27 364.20% | -8.29 57.46% | -6.44 22.34% | 7.13 210.67% | -13.28 286.33% | -13.16 0.87% | -9.31 29.28% | -7.58 18.52% | -1.61 78.82% | |
payables turnover | 0.05 - | 2.80 5,098.78% | 1.50 46.39% | 0.51 65.73% | 0.87 68.28% | 6.56 - | ||||||
receivables turnover | 0.09 - | 2.57 - | 10.77 318.44% | 6.98 - | ||||||||
research and ddevelopement to revenue | 1.15 - | 1.83 59.43% | 0.76 58.45% | 192.85 25,280.77% | 29.81 84.55% | 13.93 53.27% | 3.47 75.12% | 1.28 63.03% | ||||
return on tangible assets | -0.23 - | -0.38 67.80% | -0.68 76.45% | -0.55 19.23% | -0.95 73.34% | -0.07 92.56% | -0.61 767.57% | -0.57 7.82% | -0.30 47.10% | -0.29 2.14% | -0.59 102.97% | |
revenue per share | 0.08 - | 0.08 0.05% | 0.18 128.59% | 0.52 184.18% | 3.63 593.12% | 17.23 374.82% | 0.05 99.69% | 0.38 602.35% | 0.49 29.81% | 2.25 360.97% | 0.94 58.16% | |
roe | -0.24 - | -0.41 68.41% | -0.25 38.95% | -0.31 24.43% | -0.51 63.84% | -0.16 68.65% | -0.91 470.24% | -0.88 3.14% | -0.44 49.73% | -0.41 8.38% | -2.27 458.93% | |
roic | -0.24 - | -0.41 68.79% | -0.27 34.37% | -0.29 9.73% | -0.48 63.24% | -0.09 82.03% | -0.82 845.17% | -0.83 1.89% | -0.36 56.61% | -0.34 6.21% | -0.93 174.14% | |
sales general and administrative to revenue | 3.85 - | 11.15 189.37% | 15.30 37.29% | 0.63 95.87% | 0.56 11.90% | 0.21 62.88% | 44.02 21,199.34% | 4.57 89.61% | 2.72 40.47% | 0.55 79.89% | ||
shareholders equity per share | 3.69 - | 2.68 27.53% | 20.19 654.37% | 22.56 11.73% | 15.45 31.54% | 12.67 17.95% | 16.47 29.96% | 14.23 13.62% | 18.30 28.62% | 16.62 9.19% | 0.68 95.93% | |
stock based compensation to revenue | 0.01 - | 3.49 40,168.86% | 0.19 94.56% | 0.39 108.17% | ||||||||
tangible asset value | 8.69M - | 6.30M 27.53% | -10.36M 264.57% | 49.93M 581.79% | 24.75M 50.44% | 17.46M 29.45% | 118.51M 578.79% | 195.17M 64.69% | 382.07M 95.76% | 322.89M 15.49% | 171.34M 46.94% | |
tangible book value per share | 3.69 - | 2.68 27.53% | -4.41 264.57% | 10.50 338.34% | 4.32 58.82% | 2.66 38.40% | 10.59 297.57% | 10.78 1.75% | 16.19 50.29% | 12.63 22.02% | 0.68 94.64% | |
working capital | 8.69M - | 6.17M 29.05% | -15.97M 359.05% | 37.64M 335.68% | 10.21M 72.88% | 277K 97.29% | 108.32M 39,005.42% | 185.49M 71.24% | 341.34M 84.02% | 276.95M 18.86% | 135.14M 51.21% |
All numbers in (except ratios and percentages)